Drug: LEVEMIR Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125462911 | LEVEMIR | Foetal exposure during pregnancy | NOVO NORDISK | 0.00 | 0 | 20160711 | MA | |
125462972 | LEVEMIR | Foetal exposure during pregnancy | NOVO NORDISK | 0.00 | M | 3 KG | 20160824 | AZ |
125496491 | LEVEMIR | Foetal exposure during pregnancy | NOVO NORDISK | 0.00 | F | 0 | 20160712 | AZ |
126729121 | LEVEMIR | Foetal exposure during pregnancy | NOVO NORDISK | 0.00 | M | 3 KG | 20160822 | CL |
127365151 | LEVEMIR | Foetal exposure during pregnancy | NOVO NORDISK | 0.00 | F | 0 | 20160912 | HN |
127873841 | LEVEMIR | Foetal exposure during pregnancy | NOVO NORDISK | 0.00 | F | 1 KG | 20160928 | IL |
Total Records: 6 Number of Pages: 1